Rectal apomorphine: a new treatment modality in Parkinson's disease.
Open Access
- 1 August 1992
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 55 (8) , 737-738
- https://doi.org/10.1136/jnnp.55.8.737-a
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- ['New wine in old bottles'; therapy for Parkinson disease using subcutaneous apomorphine].1990
- Subcutaneous apomorphine in the treatment of Parkinson's disease.Journal of Neurology, Neurosurgery & Psychiatry, 1990
- Prevalence of HTLV-I-Associated Myelopathy among HTLV-I Carriers in Saga, JapanNeuroepidemiology, 1989
- SUBCUTANEOUS INFUSION OF APOMORPHINE AND LISURIDE IN THE TREATMENT OF PARKINSONIAN ON-OFF FLUCTUATIONSThe Lancet, 1987
- BLOOD TRANSFUSION AND HTLV-I ASSOCIATED MYELOPATHYThe Lancet, 1986
- HTLV-I ASSOCIATED MYELOPATHY, A NEW CLINICAL ENTITYThe Lancet, 1986
- ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESISPublished by Elsevier ,1985